Dr Reddy's Laboratories Stock News

Teaser: CBAN, CHUY, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2022.

Teaser: CBAN, CHUY, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2022.

Dr. Reddy's Laboratories Limited (NYSE:RDY ) Q4 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Amit Agarwal - Head of Investor Relations and Director of Finance Gunupati Pr

ALX, CBAN, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2022.

ALX, CBAN, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2022.

CHUY, RDY, and FBC have been added to the Zacks Rank #5 (Strong Sell) List on May 12, 2022.

CHUY, RDY, and FBC have been added to the Zacks Rank #5 (Strong Sell) List on May 12, 2022.

At meeting held on 17 March 2022

Mumbai, March 14 Benchmark indices Sensex and Nifty surged higher in the opening trade on Monday, helped by heavy buying in IT counters amid a mixed trend in Asian markets. Rising for the fifth straight session, the BSE benchmark Sensex jumped 309.91 points to 55,860.21. Similarly, the broader NSE Nifty also climbed 72.1 points to 16,702.55. In the 30-share Sensex pack, Infosys, HDFC Bank, Tech Mahindra, Wipro and State Bank of India were the major gainers. In contrast, Hindustan Unilever Limited, Mahindra amp; Mahindra, Bajaj Finance and Dr Reddy''s Laboratories were among the laggards. On Friday, the 30-share BSE Sensex had settled 85.91 points or 0.15 per cent higher at 55,550.30. The broader NSE Nifty gained 35.55 points or 0.21 per cent to close at 16,630.45. Bourses in Hong Kong and Shanghai were quoting lower, while Tokyo was trading higher during the mid-session deals. Stock exchanges in the US settled lower on Friday. Meanwhile, international oil benchmark Brent crude dipped 2.

Pharmaceutical major Dr Reddy''s Laboratories said on Wednesday it was focused on business continuity in and around Russia, as Indian drug exporters brace for temporary disruptions to sales due to the Ukraine crisis.

“Dr Reddys and Sun Pharma looks quite promising in the pharma pack. The recent correction in the market has given a decent room for a near-term upside. In the metal pack, Tata Steel looks like a value play from here. Vedanta also could do very well and the valuation looks quite promising.”

Sun Pharma the biggest gainer among Sensex firms with a jump of 3.99 per cent, followed by TCS, NTPC, Wipro, Tech Mahindra, Dr Reddy''s, UltraTech Cement and Infosys

Brokerage Radar | Jefferies has initiated coverage on Bajaj Finance shares whereas Macquarie has removed Asian Paints'' stock from its marquee buy list. Meanwhile, Macquarie has added Titan''s stock to its marquee list and believes the jewellery company should benefit from the continued momentum in market share gains. Here is a list of brokerage calls for this morning:

The second round of bids are expected by March-end, the sources said. Investment banks Edelweiss and Mape Advisory are running the sale process. Leading investors ChrysCapital, Sequoia and the promoters plan to sell Curatio Healthcare, at a valuation of ₹2,000-2,300 crore ($300 million), ET first reported in January. Feelers were sent to top buyout funds and domestic pharma majors such as Dr Reddy''s, Torrent and Cadila Healthcare.

Some recovery in the financial space and gains in heavyweights such as ITC, Dr Reddy''s and Tech Mahindra helped the headline indices trim their intraday losses.